Cargando…
Current and emerging treatment options for uveal melanoma
Uveal melanoma (UM) is the most common primary malignant intraocular tumor in adults, with a 10-year cumulative metastatic rate of 34%. The most common site of metastasis is the liver (95%). Unfortunately, the current treatment of metastatic UM is limited by the lack of effective systemic therapy. O...
Autores principales: | Pereira, Patricia Rusa, Odashiro, Alexandre Nakao, Lim, Li-Anne, Miyamoto, Cristina, Blanco, Paula L, Odashiro, Macanori, Maloney, Shawn, De Souza, Dominique F, Burnier, Miguel N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755706/ https://www.ncbi.nlm.nih.gov/pubmed/24003303 http://dx.doi.org/10.2147/OPTH.S28863 |
Ejemplares similares
-
The role of c-kit and imatinib mesylate in uveal melanoma
por: Pereira, Patricia Rusa, et al.
Publicado: (2005) -
Melanoma inhibitory activity in Brazilian patients with cutaneous
melanoma
por: Odashiro, Macanori, et al.
Publicado: (2015) -
Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006) -
Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma
por: Fernandes, Bruno F, et al.
Publicado: (2007) -
Malignancy in the blind painful eye – report of two cases and literature review
por: Pereira, Patrícia Rusa, et al.
Publicado: (2006)